Innovative Medicines Initiative to launch new call on patient engagement

The Innovative Medicines Initiative (IMI)2 Joint Undertaking is expected to launch a new topic in October focused on patient engagement in medicines Research and Development as part of the upcoming round of calls for proposals.

About the Innovative Medicines Initiative (IMI)

The Innovative Medicines Initiative (IMI) is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA. It was set up to support collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

Building a patient-led consortium

Even though the text of the call is not yet published - this will be available in September -, this call is expected to focus on fostering patient meaningful involvement throughout the research and development cycle of medicines.

EPF would like to build a patient-led consortium involving all other key stakeholders with a view to submitting a patient-centred proposal under this upcoming call.

Interested in this opportunity? Let us know!

 Should you consider that your organisation have expertise to contribute to this topic and are interested in this opportunity please get in touch with EPF Director of Programmes & Operations Walter Atzori (